PPARA and breast cancer: Among the top 10 drugs, MG-262, MG-132, celastrol, ciclopirox, and puromycin, which are also among the top drugs from the FOXM1 pathway, showed a negative correlation with the FOXM1/PPARA pathway signature, indicating their ability to reverse the pattern of gene expression in the FOXM1 and PPARA pathways in BC.